| Novartis Pharma Schweiz AG - Ilaris 150 mg/ml, Injektionslösung in einem Fertigpen |
| 70040 | | 01 | | Ilaris 150 mg/ml | | Injektionslösung in einem Fertigpen | | L04AC08 | | Canakinumab | | 04.12.2025 | | |
|
| Composition |
| canakinumabum 150 mg, mannitolum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injektionslösung in einem Fertigpen | | | | | | | | Active Agent | Dose |
|---|
| Canakinumabum | 150 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Canakinumabum | 150 mg |
| | | | Inactive agents |
|---|
| Histidin Hydrochloride Monohydrate | | Histidine | | Mannitol | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 10377.33 | 10954.95 | A | SL | No |
|
